What does the date actually describe?
A peptide COA can carry several dates: manufacture, analysis, release, report issue and a stated retest or expiry date. They answer different questions. Before comparing two offers, ask the issuer to identify each field and the batch it concerns.
For a BPC-157, GHK-Cu or Retatrutide enquiry, start with the exact material and lot reference. Then ask what dating information is available for that proposed supply. A new PDF filename, quote date or dispatch date should not be mistaken for evidence that the material itself is new.
The practical aim is a clear purchase brief and document review, not a shelf life guessed from a product name.
Read the definition with its scope.
In the pharmaceutical ICH Q7 glossary, a retest date marks when material needs another suitability examination. Its API expiry definition describes a stated period of expected specification compliance under defined storage conditions, followed by a limit on use. Read FDA’s Q7 guidance, section 20 (PDF).
These are pharmaceutical reference definitions; they do not classify our catalogue as approved APIs or establish its compliance. The issuer’s meaning and the actual offered specification still need confirmation. FDA’s Q7 questions and answers, question 7.6 (PDF), specifically explains why raw-material suppliers may use date terms differently from the API definitions.
Regional terminology also matters. Health Canada’s API guidance includes an applicable retest date within its glossary entry for expiry or expiration. See GUI-0104, Appendix A. Do not assume one printed word has an identical meaning in every document.
Keep the document timeline and material timeline separate.
| Field | Question for the issuer |
|---|---|
| Manufacture or production date | Which defined production event does it record for this lot? |
| Analysis date | Which sample and tests were examined at that time? |
| Release date | Which batch decision and accepted specification does it reference? |
| COA issue or revision date | When was this document issued, and what changed in a revision? |
| Retest date | What review becomes due, under which conditions and procedure? |
| Expiry or expiration date | What does the issuer mean, and which material, conditions and evidence does it cover? |
A blank or ambiguous field remains an open question. Ask for an unambiguous calendar format and keep the issuer’s answer with the order record.
Check the lot, result and storage history together.
Reconcile the quotation, container label and available COA using the exact material name, lot and document reference. Identify whether the stated date applies to bulk material, a filled vial or another defined presentation. Keep sampling and analysis dates attached to their results.
Q7’s COA section links identification, batch and release information with applicable expiry or retest fields. Its dating section ties API date assignments to stability-data evaluation. See sections 11.4 and 11.6. A certificate’s issue date is therefore a separate review field, not a substitute for the material’s supporting record.
For the wider evidence review, use the COA checklist and stability-report guide. Request storage and transport records where they matter to the stated dating assumptions.
State the requirement before accepting the quotation.
Tell the team your expected receipt and project schedule. Specify any required remaining period at receipt, the date field it refers to and who will assess the supporting records. Ask whether the proposed lot can meet that brief. Do not turn a requested period into an advertised guarantee.
If a date is close or has passed, request the responsible issuer’s written review and the decision for that lot. Do not create a new date yourself. FDA’s Q7 questions and answers, question 11.3, discusses API-manufacturer retest extensions in terms of scientific support, long-term stability results and batch testing, with regional requirements also relevant.
A fresh result or revised certificate is not, by itself, the complete explanation for a changed date. Ask what changed, who authorised it and which records support it.
Keep the original connection when the presentation changes.
For vials and defined pen-style kits, distinguish material dates from packing and artwork dates. A new carton, brand label or packing run does not by itself establish a new material date. If a presentation changes, ask which evidence covers the revised container and configuration.
For an OEM project, keep the original lot reference connected to the branded lot and the applicable document version. Use the reorder change-review guide for a revised offer. For GLOW, KLOW or another blend, leave unresolved identities, component amounts and totals open until confirmed; do not assign dating from one component to the whole blend by assumption.
Request the dates and the records behind them.
Send your peptide names, requested quantities, vial or defined kit presentation, destination and timing needs. Ask for the offered lot, date meanings, applicable conditions, available supporting records and any unresolved review. All Wholesale amounts, packs, formats and dating information are confirmed by enquiry.
Wholesale Lab Peptides has warehouses in the USA, Canada, Australia and Hong Kong. Confirm current local availability and domestic dispatch for the selected order. Browse the catalogue or discuss the brief through our contact page.
Discuss batch dates and documentsEmail sales@wholesalelabpeptides.com with the relevant document references.